SLC67A1 and non-small cell lung carcinoma: After confirming that NSCLC patients had aberrant expression of the SLC22A18 and SLC22A18AS genes, as identified through public databases, we investigated whether there was a genetic correlation between both genes, as observed in the second patient cohort.